Collaborative research on biomarkers and alternative methods of diagnosis and therapeutic monitoring of fibrosis-associated pulmonary hypertension

Project details

Abbreviation: bmG24

Start date: 2024-04-01End date: 2025-12-31

Budget: 5.071.530 €

Centre bugdet: 270.353 €

Funding: Elkartek 2024 (Nº de Exp.: KK-2024/00041)

Description

The bmG24 project will focus on essential aspects of EARLY DIAGNOSIS OF PULMONARY HYPERTENSION. Diagnostic, technological and therapeutic innovations will be made in two subtypes, the one associated with heart failure and the one associated with idiopathic pulmonary fibrosis.

Participants
  • Asociación Centro de Investigación cooperativa en Biomateriales.
  • Asociación bcbl Basque Benter on Cognition Brain and Language.
  • Asociación Instituto de Investigacion Sanitaria Biogipuzkoa.
  • Fundación Gaiker.
  • Fundación Cidetec.
  • Fundación Tecnalia Research & Innovation.
  • Leartiker S. Coop.
  • Fundación Centro de Tecnologías de Interacción Visual y Comunicaciones.
Activities carried out by Leartiker

Design and development of a bioreactor that simulates respiratory forces. This bioreactor will allow the models to be transported in a viable way, as well as being able to take images to control the temporal evolution, thus being able to test the different treatments and analyse their efficacy.

USE OF COOKIES

This website uses its own and third-party cookies in order to offer you the best possible user experience.

Before continuing, you must decide what to do with these cookies. You can accept all or save the selection you make.

OWN COOKIES

We use the technical cookies necessary for the operation of the website and we save your preferences for cookie settings and chosen language.

THIRD PARTY COOKIEES

We use third-party sites to analyze browsing and to display embedded information (YouTube and Flickr). Activate the desired options.

Not accepting third-party cookies will mean that we do not show you certain content. Although we will show you a link to access them.

For more information see: Privacy policy